Isracann Biosciences Stock Analysis
Isracann Biosciences is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Isracann Biosciences pink sheet analysis is to determine its intrinsic value, which is an estimate of what Isracann Biosciences is worth, separate from its market price. There are two main types of Isracann Biosciences' stock analysis: fundamental analysis and technical analysis.
The Isracann Biosciences pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Isracann Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Isracann |
Isracann Pink Sheet Analysis Notes
The company recorded a loss per share of 0.13. Isracann Biosciences last dividend was issued on the 17th of October 2019. The entity had 1:3 split on the 17th of October 2019. Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada. Isracann Biosciences is traded on OTC Exchange in the United States.The quote for Isracann Biosciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Isracann Biosciences call Phil Floucault at 604 394 2551 or check out https://www.isracann.com.Isracann Biosciences Investment Alerts
| Isracann Biosciences generated a negative expected return over the last 90 days | |
| Isracann Biosciences has high historical volatility and very poor performance | |
| Isracann Biosciences has some characteristics of a very speculative penny stock | |
| Isracann Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Isracann Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Isracann Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Isracann Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Isracann to invest in growth at high rates of return. When we think about Isracann Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.69 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Isracann Biosciences has accumulated about 310.61 K in cash with (1.75 M) of positive cash flow from operations. |
Isracann Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Isracann Biosciences's market, we take the total number of its shares issued and multiply it by Isracann Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Isracann Biosciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Isracann Biosciences Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Isracann Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Isracann Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Isracann Biosciences Outstanding Bonds
Isracann Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Isracann Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Isracann bonds can be classified according to their maturity, which is the date when Isracann Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
About Isracann Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Isracann Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Isracann shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Isracann Biosciences. By using and applying Isracann Pink Sheet analysis, traders can create a robust methodology for identifying Isracann entry and exit points for their positions.
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada. Isracann Biosciences is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Isracann Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Complementary Tools for Isracann Pink Sheet analysis
When running Isracann Biosciences' price analysis, check to measure Isracann Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isracann Biosciences is operating at the current time. Most of Isracann Biosciences' value examination focuses on studying past and present price action to predict the probability of Isracann Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isracann Biosciences' price. Additionally, you may evaluate how the addition of Isracann Biosciences to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |